BECN1 and Sepsis: Similarly, in mice treated with the autophagy-enhancing mutant Becn1F121A or Beclin-1 activating peptide (Tat-beclin-1 peptide), the adverse outcomes of KP-induced sepsis are significantly alleviated [111].